141 related articles for article (PubMed ID: 8204360)
21. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.
Weitman SD; Weinberg AG; Coney LR; Zurawski VR; Jennings DS; Kamen BA
Cancer Res; 1992 Dec; 52(23):6708-11. PubMed ID: 1330299
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells.
Forster MD; Ormerod MG; Agarwal R; Kaye SB; Jackman AL
Cytometry A; 2007 Nov; 71(11):945-50. PubMed ID: 17712798
[TBL] [Abstract][Full Text] [Related]
23. 90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.
Coliva A; Zacchetti A; Luison E; Tomassetti A; Bongarzone I; Seregni E; Bombardieri E; Martin F; Giussani A; Figini M; Canevari S
Cancer Immunol Immunother; 2005 Dec; 54(12):1200-13. PubMed ID: 15926078
[TBL] [Abstract][Full Text] [Related]
24. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma.
Franklin WA; Waintrub M; Edwards D; Christensen K; Prendegrast P; Woods J; Bunn PA; Kolhouse JF
Int J Cancer Suppl; 1994; 8():89-95. PubMed ID: 8194901
[TBL] [Abstract][Full Text] [Related]
25. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
26. Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1.
Miotti S; Bagnoli M; Tomassetti A; Colnaghi MI; Canevari S
J Cell Sci; 2000 Jan; 113 Pt 2():349-57. PubMed ID: 10633085
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines.
Miotti S; Bagnoli M; Ottone F; Tomassetti A; Colnaghi MI; Canevari S
J Cell Biochem; 1997 Jun; 65(4):479-91. PubMed ID: 9178098
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.
Müller C; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1162-70. PubMed ID: 16721570
[TBL] [Abstract][Full Text] [Related]
29. Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest.
Stein R; Goldenberg DM; Mattes MJ
Int J Cancer; 1991 Jan; 47(2):163-9. PubMed ID: 1988361
[TBL] [Abstract][Full Text] [Related]
30. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
32. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
33. Folate-binding protein is a marker for ovarian cancer.
Campbell IG; Jones TA; Foulkes WD; Trowsdale J
Cancer Res; 1991 Oct; 51(19):5329-38. PubMed ID: 1717147
[TBL] [Abstract][Full Text] [Related]
34. Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer.
Toffoli G; Russo A; Gallo A; Cernigoi C; Miotti S; Sorio R; Tumolo S; Boiocchi M
Int J Cancer; 1998 Apr; 79(2):121-6. PubMed ID: 9583724
[TBL] [Abstract][Full Text] [Related]
35. Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassay.
Mantovani L; Azzini V; Canevari S; Danzi R; Fontanelli R; Leoni F; Ménard S; Miotti S; Pasquali M; Zambetti M
Int J Biol Markers; 1989; 4(4):197-202. PubMed ID: 2483408
[TBL] [Abstract][Full Text] [Related]
36. (177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.
Zacchetti A; Coliva A; Luison E; Seregni E; Bombardieri E; Giussani A; Figini M; Canevari S
Nucl Med Biol; 2009 Oct; 36(7):759-70. PubMed ID: 19720288
[TBL] [Abstract][Full Text] [Related]
37. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.
Melani C; Figini M; Nicosia D; Luison E; Ramakrishna V; Casorati G; Parmiani G; Eshhar Z; Canevari S; Colombo MP
Cancer Res; 1998 Sep; 58(18):4146-54. PubMed ID: 9751627
[TBL] [Abstract][Full Text] [Related]
38. Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue.
Markert S; Lassmann S; Gabriel B; Klar M; Werner M; Gitsch G; Kratz F; Hasenburg A
Anticancer Res; 2008; 28(6A):3567-72. PubMed ID: 19189636
[TBL] [Abstract][Full Text] [Related]
39. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.
Parker N; Turk MJ; Westrick E; Lewis JD; Low PS; Leamon CP
Anal Biochem; 2005 Mar; 338(2):284-93. PubMed ID: 15745749
[TBL] [Abstract][Full Text] [Related]
40. The comparison of cytotoxic T-lymphocyte effects of dendritic cells stimulated by the folate binding protein peptide cultured with IL-15 and IL-2 in solid tumor.
Kim DK; Kim JH; Kim YT; Kim JW; Ioannides CG
Yonsei Med J; 2002 Dec; 43(6):691-700. PubMed ID: 12497651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
